UHS logo

Universal Health Services, Inc. Stock Price

NYSE:UHS Community·US$9.6b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 36 Fair Values set on narratives written by author

UHS Share Price Performance

US$156.63
-35.79 (-18.60%)
US$247.35
Fair Value
US$156.63
-35.79 (-18.60%)
36.7% undervalued intrinsic discount
US$247.35
Fair Value
Price US$156.63
AnalystConsensusTarget US$247.35
yiannisz US$224.48
AnalystHighTarget US$277.10

UHS Community Narratives

·
Fair Value US$247.35 36.7% undervalued intrinsic discount

Analysts Adjust Fair Value Estimates for Universal Health Services Amid Mixed Outlook and Recent Developments

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
Fair Value
·
Fair Value US$224.48 30.2% undervalued intrinsic discount

Universal Health Services Shows Why Behavioral Healthcare Is Becoming a Core Defensive Growth Sector

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$277.1 43.5% undervalued intrinsic discount

New Outpatient Facilities And Telehealth Will Unlock Secular Market Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$200.67
21.9% undervalued intrinsic discount
Revenue
4.4% p.a.
Profit Margin
8.38%
Future PE
8.49x
Price in 2029
US$241.55

Trending Discussion

Updated Narratives

UHS logo

Universal Health Services Shows Why Behavioral Healthcare Is Becoming a Core Defensive Growth Sector

Fair Value: US$224.48 30.2% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
UHS logo

UHS: 2026 EBITDA Outlook And Buybacks Will Support Future Upside

Fair Value: US$277.1 43.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
UHS logo

UHS: Future Volume Recovery Will Drive Upside From Aggressive Buybacks

Fair Value: US$247.35 36.7% undervalued intrinsic discount
16 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with outstanding track record.

2 Risks
4 Rewards

Universal Health Services, Inc. Key Details

US$17.8b

Revenue

US$9.9b

Cost of Revenue

US$7.9b

Gross Profit

US$6.3b

Other Expenses

US$1.5b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
25.12
44.23%
8.56%
61.9%
View Full Analysis

About UHS

Founded
1978
Employees
89950
CEO
Marc Miller
WebsiteView website
uhs.com

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Recent UHS News & Updates

Narrative Update May 14

UHS: 2026 EBITDA Outlook And Buybacks Will Support Future Upside

The analyst price target for Universal Health Services is updated lower to about $277 from roughly $302 as analysts factor in weaker acute segment trends, slightly softer growth and margin expectations, a higher discount rate, and a lower assumed future P/E multiple. Analyst Commentary Recent research updates on Universal Health Services are mixed, but there are some clear positive threads you should keep in mind as you assess the stock.

Recent updates

No updates